Rentschler Biopharma Purchases Facility in Massachusetts, an Industrial Info Market Brief

Rentschler Biopharma SE (Laupheim, Germany) has purchased a facility in Milford, Massachusetts from an affiliate of Shire plc. Shire has since been purchased by Takeda. The 99,000-square foot facility will continue to produce Shire/Takeda hemophilia A product Obizur on a contract basis.

Founded in 1927, family-owned and independent Rentschler has built a reputation with the development of different Interferon products (Fiblaferon, Polyferon).

Industrial Info has a complete update for this facility, including eight primary contacts.